The binding of urokinase-type plasminogen activator (uPA) to its receptor (uPAR) on the surface of tumor cells is involved in the activation of proteolytic cascades responsible for the invasiveness of those cells. The diffuse, extensive infiltration of glioblastomas into the surrounding normal brain tissue is believed to rely on modifications of the proteolysis of extracellular matrix components; blocking the interaction between uPA and uPAR might be a suitable approach for inhibiting glioma tumorigenesis. We assessed how expression of an aminoterminal fragment (ATF) of uPA that contains binding site to uPAR affects the invasiveness of SNB19 human glioblastoma cells. SNB19 cells were transfected with an expression plasmid (pcDNA3-ATF) containing a cDNA sequence of ATF-uPA. The resulting ATF-uPA-expressing clones showed markedly less cell adhesion, spreading, and clonogenicity than did control cells. Endogenous ATF expression also significantly decreased the invasive capacity of transfected glioblastoma cells in Matrigel and spheroid-rat brain cell aggregate models. ATF-uPA transfectants were also markedly less invasive than parental SNB19 cells after injection into the brains of nude mice, suggesting that competitive inhibition of the uPA-uPAR interaction on SNB19 cells by means of transfection with ATF cDNA could be a useful therapeutic strategy for inhibiting tumor progression.
Introduction
uPA is secreted as an enzymatically inactive singlechain proenzyme and binds to its natural ligand, the uPA receptor (uPAR). The binding of uPA to uPAR not only increases the enzymatic activity of uPA but also triggers a focal and directional proteolysis of extracellular matrix. uPA binds to uPAR by its aminoterminal fragment (ATF) in an interaction that involves the EGF-like domain (residues 1 -46) and exhibits species specificity between mice and humans (Quax et al., 1998) . Several strategies including the use of active site inhibitors, antibodies to uPA, and oligonucleotides or RNA directed against uPA have been used to affect the proteolytic activity or reduce the expression of uPA in tumor cells . Other attempts to abrogate the uPA/uPAR interaction use synthetic uPA-derived peptides encompassing the binding region of uPA to uPAR (Burgle et al., 1997) or recombinant soluble uPAR as a scavenger for uPA .
Tumor biology studies demonstrate a tumor suppressive role for ATF at the levels of tumor invasion and metastasis. Periodic intraperitoneal injection of an ATF-immunoglobulin G conjugate has been shown to inhibit lung metastasis of human PC3 prostate carcinoma cells, with no significant effect on primary tumor growth, in athymic mice (Crowley et al., 1993) . In another study, multiple intraperitoneal injections of a peptide from murine ATF after subcutaneous inoculation with Lewis lung carcinoma cells significantly inhibited metastatic lung tumor colonization in a dose-dependent manner (Kobayashi et al., 1994) . In a recent study, the invasiveness of a highly metastatic human lung giant-cell carcinoma cell line transfected with ATF cDNA was significantly inhibited in vitro, as was the lung metastasis of implanted cells in a spontaneous metastasis model (Zhu et al., 2001) . Li et al. (1998) also showed that adenovirus-mediated delivery of ATF suppressed growth of xenografted MDA-MB-231 human breast cancer cells or xenografted c57/BL6 syngeneic Lewis lung carcinoma cells grown in athymic mice.
Bifunctional inhibitors that include ATF or uPAderived peptides covering the human uPAR binding sequences are efficient inhibitors of the uPA -uPAR interaction. ATF conjugated with a plasmin inhibitor strongly inhibited plasmin activity at the surface of smooth muscle cells and reduced the migration of those cells (Quax et al., 2001) . ATF can also act as a growth factor for osteoblasts (Rabbani et al., 1992) . In contrast, ATF did not impart growth factor-like signals to 8701-BC breast carcinoma cells but rather restricted the invasion of these cells in vitro (Luparello and del Rosso, 1996) . At present, the effect of ATF on glioblastoma cell invasiveness is poorly understood.
We showed previously that uPA is overexpressed in glioblastoma cell lines and tumor tissues (Mohanam et al., 1993; Yamamoto et al., 1994a) . Selective inhibition of the uPA -uPAR interaction may be an effective means of decreasing the invasiveness of human glioblastoma cells. The underlying molecular mechanism of ATF remains elusive, and the role of ATF in glioma cells has not been studied. To address this gap, we generated stable, ATF-expressing transfectants of the glioblastoma cell line SNB19 and tested whether the interaction of uPA and uPAR could be blocked by ATF, and hence whether the invasiveness of tumor cells in vitro would be suppressed after ATF expression. We also sought to establish whether expression of the ATF fragment would reduce the tumorigenicity of the transfected cells in a nude mouse model.
Results
Transfection of SNB19 cells with ATF-uPA cDNA increases the expression of ATF mRNA and protein
We stably transfected the human glioblastoma cell line SNB19 with the pcDNA3 vector containing cDNA of ATF-uPA and grew the cells in medium containing G418 to allow selection of drug-resistant colonies. Parental cells and clones transfected with an empty vector served as controls.
To verify that the ATF-uPA-transfected clones express ATF mRNA, we used semiquantitative reverse transcriptase -polymerase chain reaction to characterize ATF mRNA expression. Cells that had been transfected with the ATF-uPA vector showed mRNA transcripts for ATF, whereas parental cells and the vector-only transfectants did not (Figure 1 ). GAPDH, used as a control, was detected in all cell lines. To confirm that transfection with the ATF construct also resulted in expression of uPA protein, we used Western blot analysis of conditioned media and found that the ATF protein band was observed only in the medium from ATF-uPA stable transfectants (ATF-3, ATF-6, and ATF-11 in Figure 2a ) and not in media from the empty vectors-transfected or parental cell lines. The ATF antibody recognized ATF-uPA transcript but uPA was below detectable level. Finally, to confirm that ATF produced by the transfectants was interacting directly with uPAR on the cell surface, the cells were washed extensively, eluted with acid buffer, and probed for ATF by Western blotting. Again, ATF was found in the ATF-transfected clones but not in the control cell lines (Figure 2b ), indicating that the ATF secreted by the transfected cells was able to bind on the surface of those cells.
Secretion of ATF reduces cell surface-associated uPA activity ATF competes with uPA for binding to uPAR. To determine whether endogenously expressed ATF binds to uPAR and displaces uPA, we studied cell surfaceassociated uPA by washing the cells thoroughly with serum-free medium, extracting them with acid buffer (pH 3.0), and analysing cell surface-associated uPA activity by fibrin zymography. Cell-surface uPA activity was much lower in the ATF-transfected SNB19 cells than in the parental or vector-control cells (Figure 3 ).
ATF expression alters adhesion, spreading, and colony formation
After we discovered that the ATF transfectants had reduced cell surface-associated uPA activity, we tested them for adhesion and spreading capabilities. Consid- 
Changes in actin cytoskeleton organization due to ATF expression
Because the cytoskeleton plays a major role in cell spreading, we next examined stress-fiber reorganization in parental cells and G418-resistant ATF-transfected clones to determine whether the change in cell adhesion resulted from changes in cytoskeleton organization. In the ATF stable transfectants, stress-fiber organization was severely disrupted, as evidenced by the absence of networks of stress fibers forming during cell spreading ( Figure 7 ).
Decreased invasive potential among transfected clones
Since ATF interferes with the interaction between uPA with uPAR, we assessed its ability to inhibit cell invasion in vitro in Matrigel and spheroid coculture invasion assays. No marked differences in invasiveness were noted between the parental cells and the vectortransfected control cells in either assay. However, the invasive potential of the ATF-uPA-transfected clones was substantially inhibited in both assays. In the Matrigel assay, quantitative analysis of invading cells by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltertrazolium bromide (MTT) indicated that at 48 h, 45% of the parental cells and 42% of the empty-vectortransfected clones had traversed the membrane; in contrast, the invasiveness of the ATF-transfected clones was greatly reduced (10% ATF-3, 25% ATF-6, and 16% AFT-11) (Figure 8 ). In the spheroid coculture assays, spheroids consisting of parental SNB19 cells or vector transfectants attached to and invaded the fetal rat brain aggregates by 72 h of coculture, but spheroids consisting of the ATFexpressing clones did not (Figure 9a ).
Expression of ATF reduces tumor growth in nude mice
Finally, to determine whether the expression of ATF is associated with inhibition of tumor growth in vivo, we injected the brains of nude mice with parental SNB19 cells, vector-transfected controls, or ATF-transfected cells and assessed the growth of the implanted cells. All mice injected with parental SNB19 cells developed tumors. In contrast, mice injected with the ATF-3 transfectant showed markedly reduced tumor formation at 4 weeks after injection; the presence of smaller tumors was confirmed by histologic examination (Figure 9b ).
Discussion
The coordinated interaction of different proteolytic systems is important for tumor cell invasion and metastasis (Duffy, 1996) . The invasive capacity of tumor cells can be suppressed by synthetic inhibitors directed against various proteases or by plasminogen activator system antagonists (Min et al., 1996; Festuccia et al., 1998) . The uPA system has pivotal roles in tumor growth, angiogenesis, and metastasis. Earlier studies focused on the proteolytic cascades initiated by uPA and mediated by the catalytic B chain, which resulted in matrix remodeling and allowed tumor cell invasion and migration (Reuning et al., 1998; Schmitt et al., 2000) . The binding of uPA to uPAR has been shown to mediate various other signaling cascades (Dear and Metcalf, 1998) , although the role of these cascades in tumor progression is poorly understood. uPA and uPAR are expressed by many tumor types, and their expression correlates with tumor progression and poor prognosis (Duffy, 1996) . This association is consistent with the hypothesis that plasminogen activation contributes to the invasive phenotype of tumor cells. Glioblastoma cells and tumor tissues exhibit levels of uPA and uPAR that increase in parallel with tumor grade (Yamamoto et al., 1994a,b) . Down-regulation of uPA or uPAR in glioblastoma cells results in reductions in invasiveness and tumorigenicity (Mohanam et al., , 2001 Go et al., 1997) . Since the uPA -uPAR system contributes to the invasion and motility of several cell types associated with tumor progression (e.g., endothelial and tumor cells), we hypothesized that the inhibition of the uPA -uPAR interaction would have significant anti-tumor effects.
Several previous studies suggest a possible role for uPA or uPAR in cell adhesion and migration independent of the enzymatic activity of the uPA (Stahl and Mueller, 1997; Waltz et al., 2000) . Cell adhesion and spreading are the result of cooperative actions among adhesive systems. However, until now, the direct role of blocking uPA -uPAR interaction by ATF has not been explored in glioblastoma cells. Our results demonstrate that forced expression of ATF in glioma cells led to decreased cell adhesion, which could be due to the reduction in number of uPA -uPAR complexes. The molecular mechanism by which ATF affects cell adhesion is not yet clear, but the results presented here suggest that ATF may modulate cell adhesion and spreading by stimulating the reorganization of the cytoskeleton. Alternatively, ATF expression could have a regulatory function in adhesion-induced signal transduction events, which in turn lead to a reorganization of the cytoskeleton. We monitored endogenous ATF-induced reorganization of the actin cytoskeleton by rhodamine-labeled phalloidin staining and found that expression of ATF also had a significant effect on actin reorganization in SNB19 glioblastoma cells. The parental cells showed intensely staining, closely packed fine microfilament bundles oriented to the long axes of the cells and terminating at focal contacts. The ATF-transfected cells, in contrast, exhibited membrane ruffling and irregular networks of microfilaments throughout the cytoplasm but did not form focal adhesions or actin stress fibers. Notably, intensification of adhesion-induced lamellae and formation of filopodia were absent in the ATF-expressing transfectants. In summary, ATF expression diminished adhesion and spreading and is associated with reorganization of the actin cytoskeleton.
Tumor cell invasiveness is a complex multistep process that involves cell adhesion, proteolysis of the (Andreasen et al., 1997) . In this study, we showed that expression of ATF by cDNA transfection reduced cellular invasiveness in both Matrigel and spheroid coculture invasion assays. These findings are in accord with earlier reports of ATF expression in a human lung giant-cell carcinoma cell line (Zhu et al., 2001) . Our results with the Matrigel assay support the idea that the interaction of uPA with the cell surface is crucial for invasion through Matrigel, which contains a mixture of extracellular membrane components. To confirm these findings, we used a three-dimensional spheroid coculture model that more closely mimics in vivo invasion into a complex and intact extracellular membrane synthesized by fetal rat brain aggregates. We confirmed that spheroids from the ATF-transfectants invaded fetal rat brain aggregates to a much lesser extent than did spheroids from parental and vector control cells. The efficacy of ATF in suppressing invasiveness may lie in the possibility that ATF has additional effects apart from its direct effect on blocking uPA to its receptor, such as decreasing plasminogen activation by making uPAR less accessible for uPA or inhibiting the plasmin-mediated activation of other matrix-degrading enzymes such as proenzyme forms of matrix metalloproteinases. Since localized plasmin inhibition seems to be an essential route to inhibiting invasion, ATF is an interesting candidate for therapeutic inhibition of cell invasiveness.
If the presence of cell surface-bound uPA is a key determinant of invasion, then inhibiting the interaction of uPA with uPAR should translate into a measurable reduction in invasiveness. Thus, blocking the binding of uPA to uPAR by the expression of ATF could reduce the proteolysis mediated by cell surface-associated uPA in tumor cells. We tested the tumorigenicity of parental cells and ATF transfectants in nude mice with an intracerebral implantation method; the ATF transfectants formed smaller tumors than did parental cells, which showed typical invasive behavior and progressive tumor growth. Earlier, lung dissemination of Lewis lung carcinoma cells was shown to be significantly reduced after intratumoral injection of an adenovirus containing murine ATF at the primary site; also, systemic administration of this construct inhibited subsequent liver metastasis in a LS174T human colon carcinoma xenograft model (Li et al., 1998) . We also found that endogenous expression of ATF reduced cell adhesion, cell spreading, and colony formation as well as suppressing tumor growth. In our study, ATF is found associated with cells suggesting that it may interact with uPAR. Because the uPAR and uPA molecules associated with the plasminogen activation system on the cell surface are of fundamental importance in cell biology, the addition of an antagonist of plasminogen activators such as ATF may not only shift the balance in the enzymatic activity of the uPAuPAR complex, but may also trigger further cellular responses. Our study indicates that the inhibition of uPA -uPAR interaction, a key step in tumor progression, could constitute a new therapeutic approach for the control of both tumor cell growth and invasion.
Materials and methods

Cell cultures
SNB19 glioblastoma cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum in a humidified atmosphere containing 5% CO 2 at 378C and subcultured every 3 -5 days. Figure 9 (a) ATF expression inhibits the invasion of SNB19 cells through rat-brain aggregates. Confocal laser scanning images of SNB19 spheroids and rat-brain aggregate cocultures scanned at a depth of 100 mm from the spheroid surface. The rat-brain aggregates appear green and the tumor cell spheroids appear red. Four -five tumor spheroid/rat brain aggregate confrontations were carried out in each group to confirm the reproducibility. (b) Tumorigenicity of parental and ATF-transfected SNB19 (ATF-3) cells in the brains of nude mice. Five mice were injected in each group and after 4 weeks the mice were sacrificed, tumors tissues were removed, sectioned and stained. A photomicrograph of a tumor section stained with hematoxylin and eosin shows that tumors that formed in tissues derived from ATF-transfected cells injected into the mouse brain were much smaller than those derived from the parental SNB19 cells. All the animals examined in each group showed identical results
Preparation of constructs
A cDNA fragment encoding amino acids 1 -155 of uPA, isolated by polymerase chain reaction (PCR) with sense (5'-ATAAGCTTGCCGCCGTCTAGCGCCCCGA-3' including an HindIII site) and antisense (5'-GCGGATCCTCA-CTTTTTTCCATCTGCGCAGTC 3' including BamHI site) primers was subcloned into HindIII and BamHI cut pcDNA3 expression vector (Invitrogen, Carlsbad, CA, USA). The orientation and sequence of the insert was confirmed by automated sequencing.
Transfection of SNB19 cells
The SNB19 cells were transfected with the ATF-uPA pcDNA3 construct or with pcDNA3 vector alone by using lipofectin (Invitrogen, Carlsbad, CA, USA) as described elsewhere . Stable transfectants were initially selected by using cloning cylinders after 3 -4 weeks of culture in medium containing G418 (800 mg/ml).
Reverse transcriptase -polymerase chain reaction
Cells were washed with ice-cold PBS and total RNA was extracted with the TRIzol reagent (Invitrogen, Carlsbad, CA, USA). RNA was first treated with DNase at 378C for 1 h and then reverse-transcribed by using a cDNA cycle kit (Invitrogen, Carlsbad, CA, USA) and random primers. To amplify the cDNA, a 1-ml aliquot of the reverse-transcribed cDNA was subjected to 30 cycles of RT -PCR in 25 ml of PCR Master Mix (Promega, Madison, WI, USA) buffer containing 100 ng of sense and antisense primers. The efficiency of cDNA synthesis was estimated by RT -PCR with GAPDH-specific primers. The following sense (S) and antisense (AS) primers were used in RT -PCR reactions: ATF (S, 5'-ATAAGCTTGCCGCCGTCTAGCGCCCCGA; AS, 5'-GCGGATCCTCACTTTTTTCCATCTGCGCAGTC-3'; amplicon size 524 bp); GAPDH (S, 5'-CGGAGTCAACG-GATTTGGTCGTAT-3'; AS, 5'-AGCCTTCTCCATGGT-GGTGAAGAC-3'; amplicon size 307 bp). Samples were subjected to electrophoresis on a 1.5% agarose gel and photographed as ethidium bromide fluorescent bands.
Electrophoresis and Western blot analysis
Equal amounts of protein from serum-free media were loaded onto 15% minigels and separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS -PAGE). Resolved proteins were electrophoretically transferred to nitrocellulose membrane (BioRad, Hercules, CA, USA). The membrane was then blocked with 5% lowfat dry milk in TBS-T (10 mM Tris pH 7.2, 50 nM NaCl, 0.2% Tween 20) for 1 h at room temperature and incubated with primary antibody at 48C for 18 h. Blots were washed extensively with TBS-T and incubated with 1 : 5000 dilution of horseradish peroxidase (HRP)-conjugated secondary antibody (Amersham Pharmacia Biotech, Piscataway, NJ, USA) diluted in TBS-T containing 3% BSA for 1 h at room temperature. Labeled proteins were visualized by enhanced chemiluminescence (Amersham Pharmacia Biotech, Piscataway, NJ, USA). Mouse monoclonal antibodies against human ATF were obtained from American Diagnostica (Greenwich, CT, USA).
Fibrin zymography
The enzymatic activity and molecular weight of electrophoretically separated forms of PA were determined in acid-wash extracts and conditioned medium of all the clones and parental cells by SDS -PAGE as described previously . Briefly, the SDS -PAGE gel contains acrylamide to which purified plasminogen and fibrinogen were added as substrates before polymerization. After polymerization, equal amounts of proteins in the samples were electrophoresed and the gel was washed twice with 2.5% Triton X-100 for 30 min each time, and the gel was incubated at 378C overnight with glycine buffer (pH 7.5). After staining with Coomassie blue and destaining, the final gel has a uniformly blue background except in regions to which PAs have migrated and activated the plasminogen to form plasmin.
Cell spreading
Cells suspended in serum-free medium were added to 96-well microtiter plates (10 4 cells per well) and allowed to attach and spread for 2 h. After this incubation, the medium containing non-adhered cells was poured off and the cells were fixed for 30 min with a solution of 3.7% formaldehyde and 5% sucrose. The cells in at least three parallel fields in each of four wells were analysed by phase contrast microscopy. An individual cell was counted as having spread when its diameter was at least twice that of the nucleus. The percentage of spread cells was evaluated as (number of spread cells divided by total of number cells in field6100= percentage of spreading.
Adhesion assays
Cells were harvested, washed three times with serum-free medium, and allowed to adhere tissue culture plates for 2 h at 378C. Cells were then washed three times with HEPES buffer and fixed with 2.5% formaldehyde in PBS, stained with 0.5% crystal violet in 20% (v/v) methanol/water, and viewed under a microscope. The amount of bound cells was estimated by solubilizing the dye with 0.1 M sodium citrate and reading the absorbance at 570 nm. Quadruplicate determinations were done for each condition and analysed for statistical significance
Staining of actin cytoskeleton
Cells were fixed in 3% paraformaldehyde in phosphatebuffered saline for 15 min followed by permeabilization with 0.5% Triton X-100 in phosphate-buffered saline for 5 min. After being washed three times with phosphate-buffered saline, the specimens were incubated with rhodamineconjugated phalloidin for 30 min. Staining of actin was observed under a confocal laser scanning microscope (Olympus, Tokyo, Japan).
Colony formation
Cells (4610 3 ) were plated on 100-mm tissue culture dishes and the medium was changed every 3 days. After 2 weeks, the resulting colonies were fixed in methanol and stained with Hema-3.
Matrigel invasion assay
Cells were plated on Matrigel-coated cell-culture inserts in Transwell chambers (Corning Inc, Corning, NY, USA) containing 12-mm filters (pore size 8 mm) as follows. Matrigel (Beckton Dickinson, Bedford, MA, USA) was diluted with cold, serum-free medium and 150 mg was applied to each filter, which were then dried in a hood and incubated at 378C for 30 min. Cells (1610 5 ) were suspended in serum-free medium, added to the Matrigel-coated chamber, and conditioned medium was placed in the lower chamber as a chemoattractant. After incubation for 48 h at 378C in 5% CO 2 , the Matrigel-coated side of the filter was removed with a cotton swab and cells on the opposite side of the filter were fixed in 10% formaldehyde, stained with hematoxylin and eosin, and counted. Each assay was performed in quadruplicate.
Coculture invasion assay
Spheroids of fetal rat brain cells and tumor cells were prepared as described elsewhere . Briefly, brain cells obtained from 18-day-old fetuses of SpragueDawley rats were cultured for 16 days, after which aggregates 100 -200 mm in diameter were selected for the experiments. Fetal brain cell aggregates were stained with 3,3'-dioctadecyloxacarbocyanine perchlorate (DiO). Multicellular tumor-cell spheroids of parental cells, empty-vector-transfectants, and uPA-ATF stable transfectants were grown separately on 0.75% agar-coated plates and stained with 1,1 dioctadecyl-3.3.3'.3'-tetramethylindocarbocyanine perchlorate (DiI). For the coculture, the DiI-stained tumor spheroids and DiOstained fetal rat-brain aggregates were washed in medium and transferred in quadruplicate to individual wells of a 96-well plate that had been base-coated with agar. A sterile syringe and stereomicroscope were used to place the tumor spheroids and fetal rat-brain aggregates in close contact with each other. At different times thereafter, serial optical sections were obtained from the surface to the center of the cocultures by confocal laser-scanning microscopy, and the extent of invasion was monitored.
In vivo inhibition of tumor growth A midline scalp incision was made in nude mice, and a burr hole was made with an electric drill 2.5 mm lateral to the sagittal suture and at the coronal suture. A 10-ml cell suspension containing 2610 6 cells in serum-free medium was injected with a Hamilton syringe attached to a stereotactic frame at a depth of 3 mm. After the cells were injected, the burr hole was sealed with sterile bone wax and the scalp closed. The mice were anesthetized and killed at 4 weeks after injection. The brains were removed, fixed in 4% formaldehyde, and sliced into sections and embedded in microscopic slides. The sections were stained with hematoxylin and eosin to reveal the tumor growth.
